Clinical Trial Update: A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45 [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the safety and potential efficacy of ENTR-601-45 for Duchenne muscular dystrophy that is amenable to exon 45 skipping; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• ENTR-601-45

Snippet

Sponsor: Entrada Therapeutics, Inc. | Conditions: Duchenne Muscular Dystrophy (DMD) | Phase 1, Phase 2 | Status: RECRUITING